Skin cell transplant for vitiligo treatment
Part of Skin clinical trials.
This trial tests a surgery that uses your own skin cells to treat stable vitiligo patches. It may help when creams or light therapy haven't worked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with vitiligo
- Your vitiligo has been stable (no new spots or changes) for at least 6 months to 1 year, depending on the type
- Your vitiligo covers 5% or more of your body surface area (like the size of your hand and fingers)
- You are between 8 and 65 years old
- You are willing to undergo a surgical procedure and can keep follow-up appointments
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking short courses of steroid pills alongside a skin cell transplant procedure helps treat stubborn vitiligo patches on the elbows and knees that have not improved with standard treatments.
This study tests whether adding a short course of steroid pills (taken by mouth in a pulse pattern) to a skin-grafting procedure helps prevent a pale ring from forming around the treated spots in people with stable vitiligo. The procedure takes healthy, pigment-making skin cells from one area and applies them to the white patches.
This trial tests a new treatment for non-segmental vitiligo that uses a special liquid made from stem cells, applied through tiny needle pricks or small injections, alongside standard light therapy. It may help restore pigment to white patches with fewer side effects than traditional treatments.
This study tests whether a special cell product (exosomes from umbilical cord stem cells) can safely help treat vitiligo. If you qualify, you might get this experimental treatment to see if it can restore skin color.
This trial tests a new cream for vitiligo on the face or neck. It aims to see if the cream can help bring color back to white patches.
This study tests a new medicine called LY4005130 for non-segmental vitiligo, a skin condition where patches lose pigment (color). The trial aims to see if this drug can help restore skin color and stop the spread of white patches.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.